7 results
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
interrupted schedule (e.g ... Leishmaniasis #Prevention ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
Infections in HIV-AIDS ... Preventing CMV ... other factors (e.g ... opportunistic #infections #HIVAIDS ... #pharmacology
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Epidemiology: • 1-2 cases ... Campylobacter jejuni - HIV ... , CMV, EBV - Influenza ... Electrodiagnostic studies - EMG ... Treatment: • Plasmapheresis
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
ECG is vital while ... the determined cause ... then placed on prevention ... heartfailure #chf #criticalcare ... icu #clinical #pharmacology
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
• Thrombosis (e.g ... ET-associated mutation (e.g ... thrombocytosis (e.g ... PV, MDS, CML) Treatment ... of symptoms and prevention
IDSA Recommendations for Prevention and Treatment of Pneumocystis Pneumonia (PCP) in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
Recommendations for Prevention ... and Treatment of ... count monitoring (e.g ... opportunistic #infections #HIVAIDS ... #management #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Recommendations for Preventing ... Infections in HIV-AIDS ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology